GlassScriptPhysician profile
Stephanie Lowe
NPI 1306598016
$2,144.56
in general payments reported to CMS, 2019-2025
17 companies · $13.57 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $79.75 · 2023: $159 · 2024: $1,892 · 2025: $13.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116 · Travel and Lodging: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.47 |
| Travel and Lodging | $948.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $936.76 | 2023-2025 | General - Pain Management |
| Curonix LLC | $549.72 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $313.88 | 2023-2024 | Eterna, Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.18 | 2023-2024 | Relistor |
| Ironshore Pharmaceuticals INC. | $34.40 | 2023 | Jornay Pm |
| Saluda Medical Americas, INC. | $33.11 | 2024 | Evoke |
| Nalu Medical, INC. | $33.03 | 2023-2024 | Nalu Neurostimulation System |
| Lucid Diagnostics INC. | $31.40 | 2022 | |
| Depuy Synthes Sales INC. | $21.37 | 2024 | Monovisc, Orthovisc |
| Lundbeck LLC | $19.55 | 2024 | Vyepti |
| Antares Pharma, INC. | $18.31 | 2023 | Xyosted, Tlando, Nocdurna |
| Alnylam Pharmaceuticals INC. | $17.95 | 2023 | Amvuttra |
| Biohaven Pharmaceutical Holding Company LTD. | $17.74 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.40 | 2022 | |
| Exeltis, USA INC. | $15.34 | 2023 | Slynd |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.21 | 2023 | |
| Novo Nordisk INC | $13.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.